Based on its recent analysis of the non-melanoma skin cancer therapy market, Frost & Sullivan recognizes Sensus Healthcare LLC with the 2014 North American Frost & Sullivan Award for New Product Innovation Leadership. Sensus uses a technique known as superficial radiation therapy (SRT) in its two low-energy X-ray devices, SRT-100™ and SRT-100 Vision™. Low energy X-rays are often used for medical imaging and for the treatment of certain cancers. The SRT-100™ and SRT-100 Vision™ devices are superior to other available treatments of non-melanoma skin cancer and other skin conditions. They offer unrivaled value to patients and physicians through safe, effective, and virtually pain- and scar-free treatment options.